| Literature DB >> 33538394 |
Takahiro Komori1, Satoshi Hoshide1, Ken-Ichi Tabei2, Hidekazu Tomimoto2, Kazuomi Kario1.
Abstract
White matter hyperintensities (WMHs) are risk factors for future cognitive impairment and are associated with an abnormal circadian blood pressure (BP) rhythm in patients with hypertension. However, whether this association exists in patients with heart failure (HF) is unclear. We performed a cross-sectional study of hospitalized patients with HF who underwent ambulatory BP monitoring and brain magnetic resonance imaging (MRI). A non-dipper BP pattern was defined as a < 10% nocturnal BP decline. WMHs on brain MRI scans were quantitated using a novel image analysis software (FUSION: FUsed Software for Imaging Of Nervous system). We enrolled 28 hospitalized patients with HF (age: 70.0 ± 9.8 years, 64.3% men). In the brain MRI analysis, the non-dipper group had higher WMH volume (18.9 ± 19.8 vs. 7.7 ± 8.3 mL, P = .047) and percentage of WMH/total brain volume (1.31 ± 1.28% vs. 0.55 ± 0.58%, P = .04) than the dipper group. In conclusion, using the newly developed MRI analysis software, we successfully quantitatively measured the volume of WMHs and found that the WMH volume increased 2.4 times in patients with a non-dipper pattern of nocturnal BP compared with those with a normal dipper pattern.Entities:
Keywords: blood pressure; circadian rhythm; heart failure; white matter hyperintensity
Mesh:
Year: 2021 PMID: 33538394 PMCID: PMC8678785 DOI: 10.1111/jch.14204
Source DB: PubMed Journal: J Clin Hypertens (Greenwich) ISSN: 1524-6175 Impact factor: 3.738
Figure 1Quantitative evaluation of white matter hyperintensity. (A) Brain imaging scan of a patient with a non‐dipper blood pressure pattern. A large amount of WMHs was detected (left image). Image before software analysis (right image). (B) Brain imaging scan of a patient with a dipper pattern. The amount of WMHs was small (left image). Image before software analysis (right image)
Baseline characteristics
| Variables | Non‐dipper ( | Dipper ( |
|
|---|---|---|---|
| Age, years | 70 ± 9 | 69 ± 11 | 0.76 |
| Male sex, | 10 (55.6) | 8 (80.0) | 0.19 |
| Body mass index, kg/m2 | 21.4 ± 4.7 | 22.8 ± 3.4 | 0.43 |
| IHD, | 5 (27.8) | 5 (50.0) | 0.22 |
| Non‐IHD, | 13 (72.2) | 5 (50.0) | 0.22 |
| HFpEF, | 7 (38.9) | 5 (50.0) | 0.70 |
| History of hypertension, | 12 (66.7) | 7 (77.8) | 0.45 |
| Diabetes, | 5 (27.8) | 4 (44.4) | 0.33 |
| Atrial fibrillation, | 10 (55.6) | 4 (40.0) | 0.35 |
| Cardiovascular drugs | |||
| ACE inhibitor, | 7 (41.2) | 5 (50.0) | 0.48 |
| ARB, | 8 (47.1) | 4 (40.0) | 0.52 |
| β‐blocker, | 16 (94.1) | 10 (100) | 0.63 |
| Diuretics, | 15 (88.2) | 7 (70.0) | 0.25 |
| Laboratory and physiological examinations | |||
| Creatinine, mmol/L | 1.3 ± 0.4 | 1.5 ± 0.6 | 0.35 |
| Hemoglobin, g/dL | 15.8 ± 8.0 | 13.4 ± 2.2 | 0.36 |
| NT‐proBNP, pg/mL | 1340 (1074, 2360) | 891 (495, 1227) | 0.35 |
| LVEF, % | 48.0 ± 15.7 | 50.8 ± 15.7 | 0.66 |
| Blood pressure and pulse rate | |||
| Casual SBP, mm Hg | 114 ± 19 | 115 ± 17 | 0.92 |
| Casual DBP, mm Hg | 67 ± 14 | 69 ± 16 | 0.83 |
| Casual PR, bpm | 66 ± 14 | 69 ± 8 | 0.59 |
| 24‐h SBP, mm Hg | 114 ± 18 | 111 ± 16 | 0.63 |
| 24‐h DBP, mm Hg | 72 ± 10 | 69 ± 7 | 0.52 |
| 24‐h PR, bpm | 63 ± 9 | 68 ± 6 | 0.22 |
| Awake SBP, mm Hg | 114 ± 17 | 116 ± 16 | 0.71 |
| Awake DBP, mm Hg | 73 ± 12 | 73 ± 7 | 0.98 |
| Awake PR, bpm | 64 ± 9 | 68 ± 7 | 0.34 |
| Sleep SBP, mm Hg | 114 ± 20 | 99 ± 15 | 0.06 |
| Sleep DBP, mm Hg | 71 ± 11 | 63 ± 7 | 0.048 |
| Sleep PR, bpm | 62 ± 11 | 67 ± 6 | 0.19 |
| Brain MRI | |||
| White matter volume, mL | 434 ± 68 | 430 ± 65 | 0.90 |
| Gray matter volume, mL | 441 ± 99 | 448 ± 27 | 0.77 |
| Total brain volume, mL | 1371 ± 138 | 1386 ± 84 | 0.73 |
| WMH volume, mL | 18.9 ± 19.8 | 7.7 ± 8.3 | 0.047 |
| WMH/total brain volume, % | 1.31 ± 1.28 | 0.55 ± 0.58 | 0.04 |
Abbreviations: DBP, diastolic blood pressure; HFpEF, heart failure with preserved ejection fraction; IHD, ischemic heart disease; LVEF, left ventricular ejection fraction; MRI, magnetic resonance imaging; NT‐proBNP, N‐terminal pro‐brain natriuretic peptide; PR, pulse rate; SBP, systolic blood pressure; WMH, white matter hyperintensity.